The Most Overlooked Gold Strategy of 2024?

This could be the key to raking in huge profits from the surging gold market in 2024.

Good Morning! 

It's Chris from Elite Trade Club, here to give you this morning's premarket trading news.

Let’s get ready to trade!

Markets 📈

America’s large-cap benchmarks eked out modest gains on Tuesday, while the Russell 2K outperformed. The DJIA was the lone loser among U.S. benchmarks.

  • Dow [-0.2%]

  • S&P 500 [+0.1%]

  • Nasdaq [+0.3%]

  • Russell 2K [+1.3%]

Futures are pointing down in early trading. S&P 500 contracts are currently down by 0.4%.

What to Watch Today:
We’ll get some updated data on Q4 GDP today at 8:30 a.m. that could shed some light on where the U.S. economy stood before entering the new year. GDP numbers don’t typically move markets, but they good provide some valuable insights for investors. We’ll also get some noteworthy tech earnings after the market closes from Snowflake, Salesforce, and HP.

There is little debate on the potential of gold in the next year and decade.

The real issue becomes - what's the best gold investment strategy today?

Some investors are opting for a unique "royalty" alternative that outshines gold bullion and volatile mining stocks.

It could be the best way to squeeze HUGE profits out of the gold market in 2024 and beyond.

» Want an Ad-Free Experience? Upgrade Now!

Premarket Highlights 🔎

📈 Bitcoin Flirts with New Highs

Bitcoin seems to be quietly tiptoeing its way back into the spotlight, reaching levels of attention it hasn't seen in a couple of years. It's not just about making headlines; it's about setting records.

According to Dow Jones Market Data, Bitcoin gracefully ascended to an all-time intraday high of $68,990.90 on November 10, 2021. This isn't just another day in the market; it's a milestone that marks Bitcoin's ongoing journey in the financial landscape.

Breaking Out 🚀
The intrigue doesn't stop at intraday achievements. Bitcoin also captured the market's attention with a record end-of-day price of $67,352.59, calculated at 4 p.m. E.T., just the day before its peak.

Currently, with a standing at about $59,399 according to the CoinDesk Bitcoin Price Index, Bitcoin seems to be modestly retreating, now sitting around 14% below its record high. It's a reminder of the cryptocurrency's dynamic nature and its unpredictable charm.

Driving Force 🚚 
What's driving this latest episode of market enthusiasm? It appears to be a combination of factors, including the introduction of new Bitcoin exchange-traded funds (ETFs) and the anticipation of the upcoming "halving" event, which is expected to reduce the rewards for Bitcoin mining.

These elements are injecting a fresh dose of optimism and speculation into the Bitcoin narrative, contributing to its current market performance.

As Bitcoin flirts with the idea of reaching new highs, the market watches with a mix of anticipation and skepticism. This latest movement is a testament to Bitcoin's enduring appeal and its capacity to spark conversation and debate within the financial community.

Whether this will lead to a new era of highs or a momentary blip in its storied existence remains to be seen.

Featured Earnings 💰️ 

  • TJX Companies [TJX] ... AM

  • Baidu [BIDU] ... AM

  • Liberty Media Corporation [FWONA] ... AM

  • Vistra [VST] ... AM

  • Endeavor Group Holdings [EDR] ... AM

  • Viatris [VTRS] ... AM

  • Salesforce [CRM] ... PM

  • Snowflake [SNOW] ... PM

  • Monster Beverage [MNST] ... PM

  • HP [HPQ] ... PM

Economy 🏗

  • GDP (first revision) [Q4] ... 8:30a

  • Advanced U.S. trade balance in goods [Jan] ... 8:30a

  • Advanced retail inventories [Jan] ... 8:30a

  • Advanced wholesale inventories [Jan] ... 8:30a

Running Hot 🔥

  • Bit Brother [BETS] >> +55.8%

  • Nauticus Robotics [KITT] >> +42.9%

  • Presto Automation [PRST] >> +40.3%

  • Oragenics [OGEN] >> (45.7%)

  • Palatin [PTN] >> (41.3%)

  • Global Gas [HGAS] >> (32.8%)

Flywire [FLYW] - Last Close: $24.52

A double-line earnings beat and optimistic revenue guidance is rallying this financial services stock this morning.

Flywire reported a surprise profit of $0.01 per share against the consensus estimate of a $(0.07) share loss. It posted a $(0.01) per share loss a year earlier.

Revenues of $100.5 million marked a significant increase from its last Q4 top-line of $73.1 million.

Flywire also posted strong Q1 and full-year 2024 revenue guidance.

FLYW is up 21.5% on more than 50K shares traded.

My Take: FLYW volume is thin but its earnings report looks pretty good. This catalyst could help the stock extend its recent uptrend.

Bandwidth [BAND] - Last Close: $12.15

Strong earnings are also boosting shares of Bandwidth, after the company posted a double-line beat on its quarterly report this morning.

The cloud-based software firm reported EPS of $0.38 on revenues of $165.39 million; topping the consensus of $0.23 EPS on $154.06 million revenues.

The company also posted Q1 and full-year 2024 guidance that surpassed analysts’ expectations.

BAND is a top mover with a 30.7% gain on roughly 75K shares traded.

My Take: BAND’s earnings beat could help it break out of its recent downtrend, but expect resistance at the $15 mark.

Beyond Meat [BYND] - Last Close: $7.52

An earnings beat and a newly announced cost-cutting initiative are lifting shares of this alternative meat stock in early trading.

Beyond Meat reported a 7.8% decline in revenues, but managed to top the Street’s consensus with a $73.7 million top-line figure.

Its operating loss more than doubled to $(2.40) per share from $(1.05) per share a year ago.

The company also announced plans to increase its prices and “steeply” cut costs in 2024.

BYND is up 56.6% on nearly 5 million shares traded.

My Take: BYND’s revenues were down, its operating loss widened, and its still nowhere close to turning a profit. This rally is running on pure hype, I would stay away unless you have a solid plan.

Icannex Healthcare [IXHL] - Last Close: $4.22

Positive top-line data from a Phase 2 Psi-GAD1 clinical trial of psilocybin for generalized anxiety disorder is rallying this micro-cap biotech stock.

Icannex said the trial achieved its primary endpoint and demonstrated statistically significant reductions in therapeutic benchmarks.

IXHL is up 86.0% on roughly 5 million shares traded.

My Take: IXHL could get a boost from the hype surround alternative medicines like psylocybin, which is the active ingredient in Magic Mushrooms.

That's it for today! Thanks for reading, and good luck out there!

Best Regards,

— Chris D.
Elite Trade Club

Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Join Insider NOW to access
to this report!